Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00378521
What this trial is testing

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease
MediQuest Therapeutics 15
Post-approval studies (Phase 4)Ended earlyNCT03639766
What this trial is testing

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University of Central Florida 3
Not applicableStudy completedNCT03094910
What this trial is testing

Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon

Who this might be right for
Raynaud DiseaseRaynaud PhenomenonHand and Arm Vibration Syndrome+5 more
Herlev Hospital 174
Testing effectiveness (Phase 2)Study completedNCT00480753
What this trial is testing

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
MediQuest Therapeutics 15
Post-approval studies (Phase 4)Looking for participantsNCT07112183
What this trial is testing

Open Label Treprostinil Raynaud's Study

Who this might be right for
Raynaud's DiseaseRaynaud PhenomenaRaynauds
Brigham and Women's Hospital 30
Not applicableStudy completedNCT02212249
What this trial is testing

Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis

Who this might be right for
Primary Raynaud DiseaseSystemic Sclerosis
University Hospital, Grenoble 85
Testing effectiveness (Phase 2)Study completedNCT03867097
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 34
Post-approval studies (Phase 4)Study completedNCT00048763
What this trial is testing

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Otsuka America Pharmaceutical 75
Large-scale testing (Phase 3)Study completedNCT00626665
What this trial is testing

Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

Who this might be right for
Raynaud Disease
Sanjay Gandhi Postgraduate Institute of Medical Sciences 25
Testing effectiveness (Phase 2)Study completedNCT01090492
What this trial is testing

PF-00489791 For The Treatment Of Raynaud's

Who this might be right for
Raynaud's DiseasePeripheral Vascular Disease
Pfizer 243
Not applicableUnknownNCT05204784
What this trial is testing

Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud PhenomenonDigital Ulcer+1 more
Peter Korsten 30
Not applicableStudy completedNCT03699436
What this trial is testing

Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon

Who this might be right for
Raynaud PhenomenonRaynaud Disease
Universidad de Granada 60
Not applicableStudy completedNCT02683408
What this trial is testing

Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Primus Pharmaceuticals 87
Not applicableEnded earlyNCT02298777
What this trial is testing

Metabolomic Analysis of Systemic Sclerosis

Who this might be right for
Scleroderma (Limited and Diffuse)Undifferentiated Connective Tissue DiseaseRaynaud Disease+2 more
University Hospital, Strasbourg, France 121
Not applicableUnknownNCT03972566
What this trial is testing

Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon

Who this might be right for
CREST SyndromeCalcinosis CutisRaynaud Phenomenon
RoseLab Skin Optics Laboratory 5
Large-scale testing (Phase 3)Study completedNCT03717961
What this trial is testing

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 91
Not applicableStudy completedNCT02202291
What this trial is testing

Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon

Who this might be right for
Primary Raynaud's Phenomenon (PR)Genetic Mutations Causing PRStudy of Patients and Their Relatives (With or Without Primary PR)
Nantes University Hospital 258
Not applicableStudy completedNCT03058887
What this trial is testing

The Effects of Exercise in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud's PhenomenonQuality of Life
Sheffield Hallam University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748000
What this trial is testing

LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Liquidia Technologies, Inc. 75
Testing effectiveness (Phase 2)Ended earlyNCT04915950
What this trial is testing

Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Pfizer 13
Next Page